TSMNX
Price
$16.07
Change
-$0.10 (-0.62%)
Updated
Sep 20 closing price
VSCIX
Price
$113.13
Change
-$0.77 (-0.68%)
Updated
Sep 20 closing price
Ad is loading...

TSMNX vs VSCIX

Header iconTSMNX vs VSCIX Comparison
Open Charts TSMNX vs VSCIXBanner chart's image
Nuveen Quant Small/Mid Cap Eq I
Price$16.07
Change-$0.10 (-0.62%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index I
Price$113.13
Change-$0.77 (-0.68%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
TSMNX vs VSCIX Comparison Chart
Loading...
VS
TSMNX vs. VSCIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TSMNX is a StrongBuy and VSCIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 149B vs. TSMNX (1.38B). VSCIX pays higher dividends than TSMNX: VSCIX (1.43) vs TSMNX (0.82). TSMNX was incepted earlier than VSCIX: TSMNX (8 years) vs VSCIX (27 years). TSMNX is a more actively managed with annual turnover of: 86.00 vs. VSCIX (12.00). TSMNX has a lower initial minimum investment than VSCIX: TSMNX (100000) vs VSCIX (5000000). TSMNX annual gain was more profitable for investors over the last year : 24.85 vs. VSCIX (20.75). VSCIX return over 5 years is better than : 51.85 vs. TSMNX (34.13).
TSMNXVSCIXTSMNX / VSCIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years27 years-
Gain YTD14.0809.733145%
Front LoadN/AN/A-
Min. Initial Investment10000050000002%
Min. Initial Investment IRAN/AN/A-
Net Assets1.38B149B1%
Annual Yield % from dividends0.821.4357%
Returns for 1 year24.8520.75120%
Returns for 3 years-7.695.71-135%
Returns for 5 years34.1351.8566%
Returns for 10 yearsN/A114.15-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TGTX25.250.17
+0.68%
TG Therapeutics
SMID36.830.21
+0.57%
Smith-Midland Corp
NTR46.82-0.08
-0.17%
Nutrien Ltd
REX44.81-0.63
-1.39%
REX American Resources Corp
SABS2.56-0.21
-7.58%
SAB Biotherapeutics